Platinum Investment Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-635,798
| Closed | -$1.02M | – | 149 |
|
|
2022
Q4 | $1.02M | Sell |
635,798
-593,747
| -48% | -$950K | 0.04% | 96 |
|
|
2022
Q3 | $1.78M | Hold |
1,229,545
| – | – | 0.07% | 81 |
|
|
2022
Q2 | $2.25M | Buy |
1,229,545
+249,460
| +25% | +$456K | 0.09% | 79 |
|
|
2022
Q1 | $2.62M | Hold |
980,085
| – | – | 0.08% | 74 |
|
|
2021
Q4 | $4.24M | Sell |
980,085
-98,018
| -9% | -$424K | 0.12% | 69 |
|
|
2021
Q3 | $5.49M | Hold |
1,078,103
| – | – | 0.15% | 60 |
|
|
2021
Q2 | $6.82M | Buy |
1,078,103
+292,204
| +37% | +$1.85M | 0.16% | 56 |
|
|
2021
Q1 | $6.08M | Buy |
785,899
+482,434
| +159% | +$3.73M | 0.14% | 50 |
|
|
2020
Q4 | $1.99M | Buy |
303,465
+103,241
| +52% | +$676K | 0.05% | 91 |
|
|
2020
Q3 | $1.33M | Buy |
+200,224
| New | +$1.33M | 0.03% | 98 |
|